Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you've seen 1.25mg Mounjaro listed somewhere and wondered whether it's a real dose, the short answer is: not quite. Mounjaro (tirzepatide) does not have a licensed 1.25mg strength in the UK. The starting dose is 2.5mg, and that figure matters more than it might first appear. These are prescription-only medicines, assessed individually by a registered prescriber — not a dose you select from a menu.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro is a dual GIP and GLP-1 receptor agonist, it activates two gut-hormone pathways that regulate appetite and blood-sugar handling. Activating those pathways can cause nausea, particularly in the early weeks, which is exactly why the licensed schedule starts at the lowest available strength rather than jumping straight to a dose with full therapeutic effect.
The 2.5mg pen is explicitly described in the Mounjaro SmPC as a starter dose for tolerability, not as a maintenance or weight-loss dose. Prescribers typically hold patients here for four weeks, then step up. If you come across a reference to 1.25mg, a strength sometimes cited in non-UK sources, social-media posts, or pre-market trial summaries, it is not a strength you would be dispensed by a GPhC-registered UK pharmacy. The NHS medicines page for tirzepatide sets out the UK-licensed range clearly: 2.5, 5, 7.5, 10, 12.5 and 15mg.
That said, the 2.5mg pen is doing real work even if the number looks modest. Your system is adjusting to a new mechanism of action, and for most people that adjustment period is worth taking seriously rather than rushing through.
Once the 2.5mg phase is complete, the prescriber (not the patient) decides when and whether to move up. The standard pattern, drawn from the licensed schedule, is a step every four weeks: 2.5mg to 5mg, then 7.5mg, and so on up to the maximum 15mg. The prescriber's job at each review is to weigh tolerability against progress, which is why clinical re-review before every dose increase matters.
At a private service like nume, that means providing evidence of your current dose and weight before each step up, a real person checks the picture, not an automated system. For context on how results build across the dose ladder, the 5mg Mounjaro page covers what to expect once the starter phase is behind you.
One practical note on timing: if you're planning your first order around a bank holiday or Monday dispatch cut-off, the same-day dispatch window (order by 12pm, Monday to Friday) is worth factoring in, a Friday order placed after noon ships on Monday. Small detail, but relevant if you're counting weeks between doses.
Mounjaro's UK weight-management licence covers adults with a BMI of 30 or above, or 27 and above alongside at least one weight-related condition such as high blood pressure, type 2 diabetes, dyslipidaemia or obstructive sleep apnoea. Lower BMI thresholds apply for certain ethnic backgrounds under NICE's appraisal of tirzepatide (TA1026). BMI alone, though, doesn't determine what a prescriber decides, contraindications, existing medicines and medical history all form part of the assessment.
Mounjaro is not recommended during pregnancy, breastfeeding or if you're trying to conceive, and it is not licensed for under-18s. A history of pancreatitis or medullary thyroid carcinoma requires specific prescriber discussion before treatment is considered. For a fuller picture of who tirzepatide is intended for, the tirzepatide overview covers the eligibility criteria in more detail, and our clinical team background explains how prescriptions are reviewed at nume.
Mounjaro is a prescription-only medicine, so price and access are linked, any legitimate supply includes a clinical assessment. If you want to understand how private treatment is priced and what a transparent, all-inclusive cost looks like, the Mounjaro cost guide lays that out honestly without hidden fees. And if you're already on treatment and want to make the most of each dose, the guide to maximising Mounjaro weight loss covers the lifestyle factors that matter alongside the medicine.
The right starting point for anyone considering Mounjaro is a proper consultation, one where a prescriber reads your answers, not software. Our clinical lead's profile gives a sense of the standard that review is held to. When you're ready, you can speak to our prescribers through a free consultation, with same-day clinical review if you apply on a working day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.